Singapore markets close in 1 hour 27 minutes

Amyris, Inc. (AMRS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.1200-0.0600 (-2.75%)
At close: 04:00PM EDT
2.1000 -0.02 (-0.94%)
After hours: 07:59PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close2.1800
Bid0.0000 x 4000
Ask0.0000 x 21500
Day's range1.9800 - 2.2200
52-week range1.4700 - 17.4200
Avg. volume5,987,177
Market cap677.794M
Beta (5Y monthly)1.64
PE ratio (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Motley Fool

    Better Buy: Gingko Bioworks vs. Amyris

    Not long ago, Amyris and Gingko Bioworks were stock-market darlings, but the rout in tech stocks this year has been especially tough on these two. Shares of this synthetic biology start-up shot higher following its stock-market debut last year. The good times didn't last long, though, and now Gingko Bioworks stock is down more than 80% from its all-time high.

  • Zacks

    Amyris (AMRS) Earnings and Revenues Lag Estimates in Q1

    Amyris (AMRS) sees strong revenues in its consumer segment in Q1 driven by growth of its legacy brands and strong contribution from new brands.

  • Motley Fool

    Amyris (AMRS) Q1 2022 Earnings Call Transcript

    This call is being webcast live on the events page of the investors' section of Amyris website at You may listen to a webcast replay of this call by going to the investors' section of Amyris website. With me on today's call is John Melo, president and chief executive officer.